Terms: = Lung cancer AND ERBB3, c-erbB3, 2065, P21860, p180-ErbB3, c-erbB-3, ErbB-3, MDA-BF-1, HER3, p85-sErbB3, MGC88033, p45-sErbB3, ENSG00000065361, erbB3-S AND Clinical Outcome
9 results:
1. The Effect of GLUT1 on the Survival Rate and Immune Cell Infiltration of lung Adenocarcinoma and Squamous Cell Carcinoma: A Meta and Bioinformatics Analysis.
Zhang G; Dong R; Kong D; Liu B; Zha Y; Luo M
Anticancer Agents Med Chem; 2022; 22(2):223-238. PubMed ID: 34238200
[TBL] [Abstract] [Full Text] [Related]
2. Co-expression of receptors of the HER family correlates with clinical outcome in non-small cell lung cancer (NSCLC).
Bellezza G; Del Sordo R; Colella R; Ludovini V; Ragusa M; Bianconi F; Ferri I; Borri F; Chiari R; Puma F; Crinò L; Sidoni A
Virchows Arch; 2013 Nov; 463(5):663-71. PubMed ID: 24013863
[TBL] [Abstract] [Full Text] [Related]
3. Gene expression from bronchoscopy obtained tumour samples as a predictor of outcome in advanced inoperable lung cancer.
Suwinski R; Klusek A; Tyszkiewicz T; Kowalska M; Szczesniak-Klusek B; Gawkowska-Suwinska M; Tukiendorf A; Kozielski J; Jarzab M
PLoS One; 2012; 7(7):e41379. PubMed ID: 22848476
[TBL] [Abstract] [Full Text] [Related]
4. [Correlation of epidermal growth factor receptor mutations and HER2/3 protein expression with clinical outcome in advanced non-small cell lung cancer patients treated with gefitinib].
Han Y; Xu JM; Duan HQ; Zhang Y; Liu XQ; Zhang JS
Chin J Cancer; 2010 Jan; 29(1):69-75. PubMed ID: 20038315
[TBL] [Abstract] [Full Text] [Related]
5. EGFR mutations and HER2/3 protein expression and clinical outcome in Chinese advanced non-small cell lung cancer patients treated with gefitinib.
Xu JM; Han Y; Duan HQ; Gao EM; Zhang Y; Liu XQ; Zhang JS; Toschi L; Galetta D; Azzariti A; Paradiso A
J Cancer Res Clin Oncol; 2009 Jun; 135(6):771-82. PubMed ID: 19020901
[TBL] [Abstract] [Full Text] [Related]
6. Correlated expression of erbb-3 with hormone receptor expression and favorable clinical outcome in invasive ductal carcinomas of the breast.
Lee Y; Cho S; Seo JH; Shin BK; Kim HK; Kim I; Kim A
Am J Clin Pathol; 2007 Dec; 128(6):1041-9. PubMed ID: 18024331
[TBL] [Abstract] [Full Text] [Related]
7. Simultaneous expression of c-erbB-1, c-erbB-2, c-erbb-3 and c-erbB-4 receptors in non-small-cell lung carcinomas: correlation with clinical outcome.
Koutsopoulos AV; Mavroudis D; Dambaki KI; Souglakos J; Tzortzaki EG; Drositis J; Delides GS; Georgoulias V; Stathopoulos EN
Lung Cancer; 2007 Aug; 57(2):193-200. PubMed ID: 17442448
[TBL] [Abstract] [Full Text] [Related]
8. A five-gene signature and clinical outcome in non-small-cell lung cancer.
Chen HY; Yu SL; Chen CH; Chang GC; Chen CY; Yuan A; Cheng CL; Wang CH; Terng HJ; Kao SF; Chan WK; Li HN; Liu CC; Singh S; Chen WJ; Chen JJ; Yang PC
N Engl J Med; 2007 Jan; 356(1):11-20. PubMed ID: 17202451
[TBL] [Abstract] [Full Text] [Related]
9. Epidermal growth factor receptor inhibitors: a new prospective in the treatment of lung cancer.
Tiseo M; Loprevite M; Ardizzoni A
Curr Med Chem Anticancer Agents; 2004 Mar; 4(2):139-48. PubMed ID: 15032719
[TBL] [Abstract] [Full Text] [Related]
